cisapride has been researched along with c-peptide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, J; Horowitz, M; Jones, KL; Wishart, JM | 1 |
Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 1 |
1 trial(s) available for cisapride and c-peptide
Article | Year |
---|---|
The effect of cisapride on oral and intravenous glucose tolerance in normal subjects.
Topics: Administration, Oral; Adult; C-Peptide; Cisapride; Female; Gastrointestinal Agents; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Male; Osmolar Concentration; Piperidines; Reference Values | 1997 |
1 other study(ies) available for cisapride and c-peptide
Article | Year |
---|---|
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |